Nektar TherapeuticsNKTRNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank71
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-3.42
↑ 76% vs avg
Percentile
P71
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-14.12
Historical baseline
PeriodValueYoY Change
2025-3.42-216.6%
2024-1.08-94.4%
2023-0.56+59.3%
2022-1.37+76.4%
2021-5.79+38.9%
2020-9.47+11.0%
2019-10.64-226.6%
20188.41+108.1%
2017-103.38-645.0%
2016-13.88-